Catalytic Health Investment Platform (CHIP)

GHIC and KfW Development Bank (KfW) have partnered to launch the Catalytic Health Investment Platform (CHIP), a twenty-year partnership between GHIC and the Government of Germany, through its Federal Ministry for Economic Cooperation and Development (BMZ) and KfW, to accelerate the development of public health technologies and products to improve global health.

Building on their existing partnership, KfW and GHIC will continue to expand the GHIC model for innovative impact investment to catalyze health innovations that are responsive to the needs of people in low- and middle-income countries (LMICs). CHIP will pursue investment in funds and companies as well as grant-making opportunities with significant public health impact potential, including those relevant to health and health system resilience in LMICs. By advancing research and development, investing in technologies and products, expanding access pathways, and connecting global health to market economics, CHIP will engage diverse sectors of the health enterprise to deliver better health outcomes and health systems.​ The mission and goals of the platform align with Triple I for Global Health, a G7 global health impact initiative to which GHIC and KfW are contributing partners.

BMZ and KfW have been key strategic partners since GHIC’s formation over a decade ago by providing core funding to support GHIC efforts to catalyze investment in the field of global health product development. BMZ and KfW have provided support for GHIC’s investments in the Global Health Investment Fund (GHIF), Adjuvant Global Health Technology Fund, the Women’s and Children’s Health Technology Fund and most recently, the CHIP program.